Difficulty: Medium
Average Score: 65%
Practice
Trimethoprim inhibits bacteria without affecting mammalian cells because
Correct answer
B
Rationale
The correct answer is B) It has high affinity for bacterial but low affinity for mammalian dihydrofolate reductase enzyme. Trimethoprim, an antibiotic, selectively inhibits bacterial dihydrofolate reductase (DHFR) enzyme over the mammalian DHFR enzyme. This selectivity arises from structural differences between bacterial and mammalian DHFR enzymes. Bacterial DHFR has a higher affinity for trimethoprim compared to the mammalian enzyme, allowing the drug to target and inhibit bacterial folate synthesis while sparing mammalian cells.
Option A is incorrect because trimethoprim can penetrate mammalian cells, but its selectivity for bacterial DHFR is what allows it to selectively inhibit bacterial growth without affecting mammalian cells.
Option C is incorrect because trimethoprim specifically targets the bacterial DHFR enzyme, not folate synthetase. This is why it is able to disrupt bacterial folate synthesis while leaving mammalian cells unaffected.
Option D is incorrect because not all the statements are true. Trimethoprim's mechanism of action involves inhibiting the bacterial DHFR enzyme due to its higher affinity for the bacterial enzyme compared to the mammalian enzyme, making option B the correct choice.
Understanding the selectivity of antibiotics like trimethoprim is crucial in the field of pharmacology and microbiology. It highlights the importance of targeting unique bacterial pathways to treat infections while minimizing harm to the host. This knowledge is essential for healthcare professionals when prescribing antibiotics to ensure effective treatment with minimal side effects.
Option A is incorrect because trimethoprim can penetrate mammalian cells, but its selectivity for bacterial DHFR is what allows it to selectively inhibit bacterial growth without affecting mammalian cells.
Option C is incorrect because trimethoprim specifically targets the bacterial DHFR enzyme, not folate synthetase. This is why it is able to disrupt bacterial folate synthesis while leaving mammalian cells unaffected.
Option D is incorrect because not all the statements are true. Trimethoprim's mechanism of action involves inhibiting the bacterial DHFR enzyme due to its higher affinity for the bacterial enzyme compared to the mammalian enzyme, making option B the correct choice.
Understanding the selectivity of antibiotics like trimethoprim is crucial in the field of pharmacology and microbiology. It highlights the importance of targeting unique bacterial pathways to treat infections while minimizing harm to the host. This knowledge is essential for healthcare professionals when prescribing antibiotics to ensure effective treatment with minimal side effects.